Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

CG Oncology (CGON) Profit After Tax: 2023-2025

Historic Profit After Tax for CG Oncology (CGON) over the last 3 years, with Sep 2025 value amounting to -$43.8 million.

  • CG Oncology's Profit After Tax fell 114.69% to -$43.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$151.5 million, marking a year-over-year decrease of 108.16%. This contributed to the annual value of -$88.0 million for FY2024, which is 81.12% down from last year.
  • As of Q3 2025, CG Oncology's Profit After Tax stood at -$43.8 million, which was down 5.75% from -$41.4 million recorded in Q2 2025.
  • Over the past 5 years, CG Oncology's Profit After Tax peaked at -$8.7 million during Q1 2023, and registered a low of -$43.8 million during Q3 2025.
  • In the last 3 years, CG Oncology's Profit After Tax had a median value of -$18.9 million in 2024 and averaged -$23.3 million.
  • Data for CG Oncology's Profit After Tax shows a maximum YoY crashed of 119.16% (in 2025) over the last 5 years.
  • Over the past 3 years, CG Oncology's Profit After Tax (Quarterly) stood at -$16.6 million in 2023, then plummeted by 92.07% to -$31.8 million in 2024, then plummeted by 114.69% to -$43.8 million in 2025.
  • Its last three reported values are -$43.8 million in Q3 2025, -$41.4 million for Q2 2025, and -$34.5 million during Q1 2025.